Mode
Text Size
Log in / Sign up
N/A Completed N=701

Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Source: ClinicalTrials.gov NCT00879411 ↗
Enrolled (actual)
701
Serious AEs
0.0%
Results posted
May 2012
Primary outcomePrimary: Efficacy (Change of Systolic Blood Pressure) — 8.6 mm Hg

Summary

Practical experience report (PER) investigating the effect of Micardis® on the average 24h blood pressure of therapy-naive and therapy-experienced patients

Outcome Measures

OutcomeResultp-value
PRIMARY
Efficacy (Change of Systolic Blood Pressure)
8.6 —
PRIMARY
Efficacy (Change of Diastolic Blood Pressure)
4.7 —
SECONDARY
Overall Tolerability Scale
9.2 —

Eligibility Criteria

Inclusion criteria

  • Patients who have recently been diagnosed with hypertension
  • Patients whose current blood pressure treatment are inadequate and needs to be revised are suitable for inclusion.

Exclusion criteria

None (according to investigator)

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00879411). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search